Zions Bancorporation’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-313
Closed -$21.4K 932
2022
Q4
$21.4K Buy
+313
New +$19.9K ﹤0.01% 561
2022
Q3
Sell
-292
Closed -$18K 934
2022
Q2
$18K Sell
292
-106
-27% -$6.5K ﹤0.01% 617
2022
Q1
$26K Buy
+398
New +$27.2K ﹤0.01% 627
2020
Q1
Sell
-48
Closed -$2K 912
2019
Q4
$2K Hold
48
﹤0.01% 867
2019
Q3
$2K Hold
48
﹤0.01% 864
2019
Q2
$2K Hold
48
﹤0.01% 803
2019
Q1
$2K Buy
+48
New +$1.73K ﹤0.01% 832
2018
Q2
Sell
-2,420
Closed -$72K 470
2018
Q1
$72K Buy
2,420
+182
+8% +$5.91K 0.02% 232
2017
Q4
$77K Sell
2,238
-1,772
-44% -$58K 0.01% 279
2017
Q3
$119K Buy
+4,010
New +$115K 0.02% 366

Other funds holding BRKR

Zions Bancorporation's BRKR Position: Q1 2023 in Review

Zions Bancorporation sold out of Bruker (BRKR) in Q1 2023, closing a stake of 313 shares — an estimated $21.4K sold.

Zions Bancorporation first reported a position in BRKR in Q3 2017 and held it in 10 quarters. The position peaked at $119K in Q3 2017. 318 funds tracked by Wall St. Rank hold BRKR as of Q1 2023.

  • Zions Bancorporation reported no remaining Bruker position as of Q1 2023 after selling out during the quarter.
  • Zions Bancorporation sold 313 Bruker shares in Q1 2023, an estimated $21.4K.
  • Zions Bancorporation first reported a position in Bruker in Q3 2017 and held it in 10 quarters.
  • Zions Bancorporation's Bruker position peaked at $119K in Q3 2017.
  • 318 funds tracked by Wall St. Rank held Bruker as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.